Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Psychiatrische Praxis|August 1, 1989
[Pharmacokinetics and metabolism of reversible MAO-A inhibitors in the human]M P Schoerlin, T W GuentertActa Psychiatrica Scandinavica. Supplementum|January 1, 1990
Species-specific biotransformation of moclobemide: a comparative study in rats and humansM P Schoerlin, M Da PradaClinical Pharmacology and Therapeutics|October 1, 1987
Disposition kinetics of moclobemide, a monoamine oxidase-A enzyme inhibitor: single and multiple dosing in normal subjectsM P Schoerlin, M Mayersohn, A Korn, et al.Journal of Clinical Pharmacology|March 1, 1990
Disposition kinetics of moclobemide, a new MAO-A inhibitor, in subjects with impaired renal functionM P Schoerlin, F F Horber, F J Frey, et al.Acta Psychiatrica Scandinavica. Supplementum|January 1, 1990
Comparison of the pharmacokinetics of moclobemide in poor and efficient metabolizers of debrisoquineM P Schoerlin, R A Blouin, J P Pfefen, et al.Journal of Neural Transmission. Supplementum|January 1, 1988
Effect of food intake on the relative bioavailability of moclobemide (Ro 11-1163)M P Schoerlin, M Mayersohn, B Hoevels, et al.Clinical Pharmacology and Therapeutics|January 1, 1991
Cimetidine alters the disposition kinetics of the monoamine oxidase-A inhibitor moclobemideM P Schoerlin, M Mayersohn, B Hoevels, et al.Psychopharmacology|January 1, 1989
Plasma moclobemide and metabolites: lack of correlation with clinical response and biogenic aminesJ Fritze, G Laux, E Sofic, et al.Acta Psychiatrica Scandinavica. Supplementum|January 1, 1990
Pharmacokinetics of moclobemide after single and multiple oral dosing with 150 milligrams 3 times daily for 15 daysT W Guentert, G Tucker, A Korn, et al.The British Journal of Psychiatry. Supplement|October 1, 1989
The pharmacology of reversible monoamine oxidase inhibitorsR Amrein, S R Allen, T W Guentert, et al.Pageof 2